10.97
Precedente Chiudi:
$11.83
Aprire:
$11.08
Volume 24 ore:
601.33K
Relative Volume:
2.56
Capitalizzazione di mercato:
$241.05M
Reddito:
$52.55M
Utile/perdita netta:
$-23.69M
Rapporto P/E:
-11.67
EPS:
-0.94
Flusso di cassa netto:
$-15.29M
1 W Prestazione:
-7.74%
1M Prestazione:
+0.09%
6M Prestazione:
+82.23%
1 anno Prestazione:
+344.13%
Exagen Inc Stock (XGN) Company Profile
Nome
Exagen Inc
Settore
Industria
Telefono
(760) 560-1501
Indirizzo
1261 LIBERTY WAY, VISTA, CA
Confronta XGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
XGN
Exagen Inc
|
10.96 | 260.30M | 52.55M | -23.69M | -15.29M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
564.70 | 212.23B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
213.41 | 151.20B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
718.58 | 57.84B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
146.76 | 41.02B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
211.65 | 36.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-11 | Iniziato | B. Riley Securities | Buy |
| 2025-07-30 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-23 | Iniziato | Craig Hallum | Buy |
| 2022-08-05 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-04-15 | Iniziato | Canaccord Genuity | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-10-08 | Iniziato | BTIG Research | Buy |
| 2020-06-02 | Ripresa | Cantor Fitzgerald | Overweight |
| 2019-10-14 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-10-14 | Iniziato | Cowen | Outperform |
| 2019-10-14 | Iniziato | William Blair | Outperform |
Mostra tutto
Exagen Inc Borsa (XGN) Ultime notizie
Exagen Delivers Revenue Growth But Still Sees Losses - Finimize
Earnings call transcript: Exagen Q3 2025 reports record revenue, stock dips - Investing.com
Exagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
EXAGEN INC. SEC 10-Q Report - TradingView
Exagen Inc. (XGN) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
XGN Forecasts Positive Adjusted EBITDA by Q4 2025 - GuruFocus
XGN Reports Q3 Revenue Surpassing Expectations - GuruFocus
Exagen Inc (XGN) Q3 2025 Earnings: Revenue Surpasses Estimates a - GuruFocus
Exagen Inc. Reports Q3 2025 Financial Results with Record Revenue and Corporate Updates - Quiver Quantitative
Exagen Q3 revenue beats analyst expectations - MarketScreener
Exagen Inc. Reports Strong Q3 2025 Results - GlobeNewswire
How higher bond yields impact Exagen Inc. (E08A) stockRate Cut & High Conviction Buy Zone Alerts - newser.com
Visual trend scoring systems applied to Exagen Inc.July 2025 Short Interest & AI Powered Market Entry Strategies - newser.com
Is Exagen Inc. stock a top momentum playBuy Signal & Weekly Breakout Opportunity Watchlist - newser.com
Short interest data insights for Exagen Inc.2025 Earnings Impact & Expert Approved Momentum Trade Ideas - newser.com
Why Exagen Inc. (E08A) stock stays resilient2025 Pullback Review & Pattern Based Trade Signal System - newser.com
Strategies to average down on Exagen Inc.Weekly Trend Recap & Free Risk Controlled Daily Trade Plans - newser.com
Is Exagen Inc. stock poised for growth2025 Performance Recap & Technical Pattern Based Signals - newser.com
What To Expect From Exagen Inc (XGN) Q3 2025 Earnings - GuruFocus
Does Exagen Inc. stock trade at a discount to peers - newser.com
Is Exagen Inc. stock attractive for ETFsEarnings Overview Summary & Daily Profit Maximizing Tips - newser.com
Is Exagen Inc. (E08A) stock good for wealth creationRate Hike & High Accuracy Buy Signal Tips - newser.com
Is Exagen Inc. stock a defensive play in 2025July 2025 Drop Watch & Daily Profit Maximizing Trade Tips - newser.com
Can Exagen Inc. stock sustain revenue growthJuly 2025 Institutional & Low Risk Entry Point Tips - newser.com
Candlestick signals on Exagen Inc. stock todayTrade Exit Summary & Weekly High Return Forecasts - newser.com
Why Exagen Inc. (E08A) stock stays on buy listsRate Cut & Technical Pattern Recognition Alerts - newser.com
Exagen Inc. stock retracement – recovery analysisTrade Signal Summary & Expert Approved Momentum Trade Ideas - newser.com
Will Exagen Inc. stock split attract more investorsBull Run & Free Expert Approved Momentum Trade Ideas - newser.com
What to do if you’re stuck in Exagen Inc.Earnings Performance Report & Free Real-Time Market Sentiment Alerts - newser.com
Will Exagen Inc. benefit from macro trendsPortfolio Return Summary & Verified Swing Trading Watchlists - newser.com
What valuation ratios show for Exagen Inc. (E08A) stockGap Down & Risk Adjusted Buy and Sell Alerts - newser.com
Why Exagen Inc. (E08A) stock could be next leader2025 Dividend Review & Free Real-Time Market Sentiment Alerts - newser.com
Can trapped investors hope for a rebound in Exagen Inc.Rate Cut & Technical Pattern Recognition Alerts - newser.com
Will Exagen Inc. stock maintain momentum in 2025Weekly Investment Recap & Stock Timing and Entry Methods - newser.com
Will Exagen Inc. stock recover faster than peersGap Up & High Yield Stock Recommendations - newser.com
How to monitor Exagen Inc. with trend dashboards2025 Retail Activity & Free Weekly Chart Analysis and Trade Guides - newser.com
Detecting support and resistance levels for Exagen Inc.Weekly Trade Recap & AI Based Buy/Sell Signal Reports - newser.com
Exagen Inc Azioni (XGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):